| Literature DB >> 35010461 |
Farah Bechir1, Mariana Pacurar2, Adrian Tohati2, Simona Maria Bataga3.
Abstract
The oral cavity has specific and individualized characteristics, with pH, saliva flow, buffer capacity, temperature, and microorganisms content influencing oral health. Currently, the prevalence of gastroesophageal reflux disease (GERD) is constantly increasing. The objective of this study was to evaluate and compare the saliva quantity at 5 min, salivary pH, and salivary buffer capacity in patients with and without GERD, necessary for establishing the correct dental treatment plan. A Saliva-Check Buffer (GC) kit was used for the determination of salivary variables. The total number of 80 patients included in the study were divided into a study group and a control group, each containing 40 patients. Saliva quantity at 5 min was lower in patients suffering from GERD. The salivary pH of these patients turned to acid values compared to the salivary pH of controls, where the values were within the normal range. In patients with GERD, the determined salivary buffer capacity was low or very low. The use of the Saliva-Check Buffer (GC) kit is a simple, easy, non-invasive and patient-accepted method, which can also be used in the dentist's office to assess the saliva buffer capacity and pH, variables that are important for establishing a correct dental treatment plan.Entities:
Keywords: GERD; dentistry; saliva quantity; salivary buffer capacity; salivary pH
Mesh:
Year: 2021 PMID: 35010461 PMCID: PMC8750732 DOI: 10.3390/ijerph19010201
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Inclusion and exclusion criteria in the study group.
| Inclusion Criteria | Exclusion Criteria |
|---|---|
| GERD positive diagnosis |
Pregnancy Patients with malignancies or other serious conditions which alter the general state of health Alarm symptoms Patients with post radiation xerostomia or dryness associated with autoimmune disease Salivary gland disorders Treatment that influences saliva properties PPI therapy |
| Male and female patients, at least 18 years of age | Minors |
| Non-smokers/light smokers | Heavy smokers |
| Patient’s acceptance to participate in the study, with signed informed consent | Uncooperative patients who refused to be included in the study |
Figure 1(a) GC Saliva Check Buffer kit; (b) Placing the pH test strip; (c) Obtaining the pH value.
Figure 2(a) Saliva collected in the dispensing cup; (b) Use of a pipette to apply saliva to the test strip; (c) Buffer test value = 8, low salivary buffer capacity.
Statistical results referring to the saliva quantity at 5 min, salivary pH, and buffering capacity in the entire studied population.
| Variable | Mean | Median | SD | Min | Max |
|---|---|---|---|---|---|
| Age | 33.46 | 30 | 11.34 | 19 | 63 |
| PH | 6.29 | 6.4 | 0.7 | 5 | 7.6 |
| Quantity at 5 min | 7.1 | 7 | 1.68 | 3.5 | 11 |
| Buffer Capacity | 9.25 | 10 | 1.57 | 4 | 12 |
Statistical results referring to the saliva quantity at 5 min, salivary pH, and buffering capacity in the two studied groups.
| GERD Patients | Controls | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Variable | Mean | Frequency | Median | SD | Min | Max | Mean | Frequency | Median | SD | Min | Max | ||
| Sex | M | 18 (45%) | 14 (35%) | 0.49 | ||||||||||
| F | 22 (55%) | 26 (65%) | ||||||||||||
| Age | 34.45 | 31.5 | 10.32 | 19 | 63 | 32.47 | 30 | 12.32 | 19 | 60 | 0.44 | |||
| PH | 5.71 | 5.8 | 0.41 | 5 | 6.4 | 6.88 | 6.8 | 0.34 | 6.4 | 7.6 | 0 | |||
| Quantity at 5 min | 7.27 | 8 | 1.53 | 5 | 10 | 7.61 | 8 | 1.61 | 5 | 11 | 0.06 | |||
| Buffer Capacity | 8.57 | 8.5 | 1.39 | 4 | 10 | 9.92 | 10 | 1.47 | 6 | 12 | 0 | |||
Figure 3Correlation between salivary flow and buffer capacity for: (A) entire population, (B) GERD patients, and (C) controls.
Figure 4Correlation between pH and salivary buffer capacity for: (A) entire population, (B) GERD patients, and (C) controls.
Distribution of saliva buffering capacity.
| Saliva Buffering Capacity | |||
|---|---|---|---|
| 0–5 | 6–9 | 10–12 | |
| Entire population | 1 (1.3%) | 35 (43.75%) | 44 (55%) |
| GERD patients | 1 (2.5%) | 25 (31.25%) | 14 (35%) |
| Controls | 1 (2.5%) | 9 (22.5%) | 30 (75%) |